These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure]. Lindstedt G Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037 [No Abstract] [Full Text] [Related]
44. [Plasma brain natriuretic peptide as a useful biochemical marker of congestive heart failure]. Tsutamoto T; Horie M Nihon Rinsho; 2003 May; 61(5):782-8. PubMed ID: 12755003 [TBL] [Abstract][Full Text] [Related]
45. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure. Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of atrial natriuretic peptide and brain natriuretic peptide in atrial granules of rats with experimental congestive heart failure. Bialik GM; Abassi ZA; Hammel I; Winaver J; Lewinson D J Histochem Cytochem; 2001 Oct; 49(10):1293-300. PubMed ID: 11561014 [TBL] [Abstract][Full Text] [Related]
48. [Cardiac peptides and their importance in heart failure]. Wambach G Z Kardiol; 1991; 80 Suppl 8():41-6. PubMed ID: 1839104 [TBL] [Abstract][Full Text] [Related]
50. Brain natriuretic peptide-guided therapy in the inpatient management of decompensated heart failure. Saremi A; Gopal D; Maisel AS Expert Rev Cardiovasc Ther; 2012 Feb; 10(2):191-203. PubMed ID: 22292875 [TBL] [Abstract][Full Text] [Related]
51. Additive diagnostic and prognostic value of bioelectrical impedance vector analysis (BIVA) to brain natriuretic peptide 'grey-zone' in patients with acute heart failure in the emergency department. Di Somma S; Lalle I; Magrini L; Russo V; Navarin S; Castello L; Avanzi GC; Di Stasio E; Maisel A Eur Heart J Acute Cardiovasc Care; 2014 Jun; 3(2):167-75. PubMed ID: 24477201 [TBL] [Abstract][Full Text] [Related]
52. [Pathophysiology of heart failure and the biomarkers; brain natriuretic hormone as the class-1 recommendation by the new Japanese Guideline for Heart Failure]. Takahashi H Rinsho Byori; 2007 Dec; 55(12):1088-96. PubMed ID: 18283862 [TBL] [Abstract][Full Text] [Related]
53. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Doust JA; Glasziou PP; Pietrzak E; Dobson AJ Arch Intern Med; 2004 Oct; 164(18):1978-84. PubMed ID: 15477431 [TBL] [Abstract][Full Text] [Related]
54. Natriuretic Peptides as Biomarkers: Narrative Review and Considerations in Cardiovascular and Respiratory Dysfunctions. Samad M; Malempati S; Restini CBA Yale J Biol Med; 2023 Mar; 96(1):137-149. PubMed ID: 37009194 [TBL] [Abstract][Full Text] [Related]
60. [Rapid analysis of circulating cardiac natriuretic peptides. A new contribution to the diagnosis, regular treatment and prognosis of cardiovascular diseases]. Borgoens P; Piérard L Rev Med Liege; 2003 Oct; 58(10):615-20. PubMed ID: 14677520 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]